John Stone
Rheumatology · Boston, MANPI 1053346924
Payments from drug & device makers
Across 400 payments — averaging $17,738 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$3.9M
- Amgen$1.7M
- Principia Biopharma Inc.$854K
- E.r. Squibb & Sons, L.L.C.$292K
- Argenx US, Inc.$72K
- F. Hoffmann-la Roche AG$59K
- plus $215K from 19 others
Across 13 payments — averaging $1992.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis Pharma AG$13K
- Amgen$4K
- F. Hoffmann-la Roche AG$3K
- Argenx US, Inc.$2K
- AbbVie$2K
- Sanofi-aventis U.S. LLC$265
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 15 | $3,871,149 |
| Amgen(2 entities) | 117 | $1,731,619 |
| Principia Biopharma Inc. | 13 | $853,764 |
| E.r. Squibb & Sons, L.L.C. | 8 | $291,962 |
| Argenx US, Inc. | 34 | $72,404 |
| F. Hoffmann-la Roche AG | 39 | $59,083 |
| Sanofi | 24 | $56,182 |
| Sanofi-aventis U.S. LLC | 42 | $42,814 |
| Novartis Pharma AG | 9 | $27,737 |
| Takeda Pharmaceuticals U.S.A., Inc. | 44 | $24,172 |
| Hoffmann-la Roche Limited | 4 | $15,516 |
| GSK | 16 | $13,827 |
| Sanofi US Services Inc. | 8 | $8,873 |
| Merck | 4 | $7,350 |
| AstraZeneca(2 entities) | 3 | $4,787 |
| Genentech USA, Inc. | 1 | $4,000 |
| AbbVie(2 entities) | 4 | $3,500 |
| Regeneron | 1 | $1,740 |
| Pfizer | 1 | $1,500 |
| Novartis | 6 | $1,097 |
| Sobi, Inc | 1 | $962 |
| GRT US Holding, Inc. | 1 | $563 |
| Chugai Pharmaceutical Co., Ltd. | 1 | $420 |
| Insmed, Inc. | 3 | $189 |
| Tanabe Pharma Corporation | 1 | $30 |
How this compares
$7,095,237 in reported general payments places this provider in the 95th percentile of 265 rheumatology providers in Massachusetts.
Other rheumatology in Boston
- Sebastian UnizonyBoston$4M
- Tuhina NeogiBoston$3.7M
- George TsokosBoston$3.1M
- Tanya LaidlawBoston$1.7M
- Deepak RaoBoston$1.7M
- Katherine LiaoBoston$1.7M
- Peter NigrovicBoston$1.5M
- Marilyn PikeBoston$1.4M
- Michael BrennerBoston$1.3M
- Michael WeinblattBoston$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.